Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

QT prolongation and arrhythmia suppression.

D M Roden, R L Woosley

    American Heart Journal
    |February 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Antiarrhythmic drugs can cause dangerous QT prolongation, especially with low potassium. However, modest QT prolongation may indicate a beneficial antiarrhythmic effect, guiding future drug development.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Androgenic effects on ventricular repolarization: A translational study from the international pharmacovigilance database to iPSC-cardiomyocytes.

    Annales d'endocrinologie·2020
    Same author

    A computerized scoring system to improve assessment of heparin-induced thrombocytopenia risk.

    Journal of thrombosis and haemostasis : JTH·2018
    Same author

    New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine.

    Clinical pharmacology and therapeutics·2017
    Same author

    The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.

    Clinical pharmacology and therapeutics·2017
    Same author

    Pharmacogenetic Implementation Lessons From the "Real World".

    Clinical pharmacology and therapeutics·2016
    Same author

    A Longitudinal HbA1c Model Elucidates Genes Linked to Disease Progression on Metformin.

    Clinical pharmacology and therapeutics·2016

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • QT prolongation is a known side effect of antiarrhythmic drugs.
    • The clinical significance of QT prolongation varies, with some patients experiencing exaggerated responses and others potentially benefiting.

    Purpose of the Study:

    • To analyze the relationship between antiarrhythmic drug-induced QT prolongation and overall drug effects.
    • To differentiate between detrimental and potentially beneficial QT prolongation.

    Main Methods:

    • Review of clinical data on antiarrhythmic drug therapy.
    • Analysis of patient responses, including QT interval changes, electrolytes, and heart rate.

    Main Results:

    • Highly exaggerated QT prolongation, often with hypokalemia and bradycardia, indicates a high risk for arrhythmias.

    Related Experiment Videos

  • Modest QT prolongation may signify reduced repolarization/refractoriness dispersion, suggesting an antiarrhythmic effect.

    • Conclusions:

    • Patient risk stratification for antiarrhythmic drug therapy should consider QT prolongation.
    • Future antiarrhythmic agents should aim to reduce repolarization dispersion without inducing arrhythmias.